Novel Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors
Ram W. Sabnis
Abstract
Provided herein are novel compounds as peptidylarginine deiminase type 4 (PAD4) inhibitors, pharmaceutical compositions, use of such compounds in treating diseases, and processes for preparing such compounds.
Topics & Concepts
ChemistryCombinatorial chemistryMedicineNeutrophil, Myeloperoxidase and Oxidative MechanismsCell Adhesion Molecules ResearchNF-κB Signaling Pathways